Experienced investor and operating executive focused on growth-stage technology and healthcare companies, with expertise in corporate strategy, capital raising and operational scaling. Carrie Miller brings cross-functional experience from senior roles in private equity and venture-backed startups, advising boards on go-to-market and M&A. Active in sourcing early growth opportunities, structuring rounds and supporting management teams on commercialization and financial governance. Regular commentator in investor forums and known for pragmatic, growth-oriented value creation.
Experienced investor and operating executive focused on growth-stage technology and healthcare companies, with expertise in corporate strategy, capital raising and operational scaling. Carrie Miller brings cross-functional experience from senior roles in private equity and venture-backed startups, advising boards on go-to-market and M&A. Active in sourcing early growth opportunities, structuring rounds and supporting management teams on commercialization and financial governance. Regular commentator in investor forums and known for pragmatic, growth-oriented value creation.
Prioritizes growth-stage technology and healthcare investments where operational leverage and repeatable go-to-market can accelerate scale. Emphasizes rigorous commercial due diligence, disciplined capital allocation across tranche-based rounds, and active board-level partnership to drive revenue, margin expansion and M&A optionality. Balances conviction bets with portfolio diversification, favors companies with defensible distribution channels and strong metrics, and deploys pragmatic governance and milestone-driven capital to de-risk execution.
Prioritizes growth-stage technology and healthcare investments where operational leverage and repeatable go-to-market can accelerate scale. Emphasizes rigorous commercial due diligence, disciplined capital allocation across tranche-based rounds, and active board-level partnership to drive revenue, margin expansion and M&A optionality. Balances conviction bets with portfolio diversification, favors companies with defensible distribution channels and strong metrics, and deploys pragmatic governance and milestone-driven capital to de-risk execution.
| Trades 392 | Longs Won 309/392 78% | Profit Factor 78.03 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.43M |
| Average Win $367,696.41 | Best Trade (Oct 14) $15.88M | Sharpe Ratio -70.93 |
| Average Loss -$17,544.14 | Worst Trade (Oct 14) -$166,926.53 | Z-Score 8.29 (100%) |
| Commissions $0 | Avg. Trade Length 1y 8m 2w 1d | Expectancy $286,127.62 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.02% |
| Consecutive Losing Trades | 16,667 | 15,000 | 13,333 | 11,667 | 10,000 | 8,333 | 6,667 | 5,000 | 3,333 | 1,667 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 2,708 | $630,972.68 | $929,561.62 | - | $298,588.94 | 47.32% | +0.089% |
AMZN Amazon.com Inc | 20,735 | $4.32M | $5.25M | - | $934,525.9 | 21.64% | -0.291% |
AVDE Avantis International Equity ETF | 250,006 | $13.76M | $22.36M | - | $8.6M | 62.54% | +0.207% |
AVDV Avantis International Small Cap Value ETF | 2,211 | $220,888.09 | $236,090.58 | - | $15,202.49 | 6.88% | -0.466% |
AVEM Avantis Emerging Markets Equity ETF | 80,537 | $4.22M | $7.25M | - | $3.03M | 71.64% | -1.099% |
AVSD Avantis Responsible International Equity ETF | 24,959 | $1.33M | $1.97M | - | $633,571.62 | 47.55% | +0.525% |
AVSE Avantis Responsible Emerging Markets Equity ETF | 8,552 | $410,403.09 | $644,222.16 | - | $233,819.07 | 56.97% | -1.536% |
AVSU Avantis Responsible U.S. Equity ETF | 31,912 | $1.77M | $2.82M | - | $1.05M | 59.09% | +0.193% |
AVUS Avantis U.S. Equity ETF | 205,672 | $14.5M | $26.61M | - | $12.11M | 83.56% | +0.093% |
AVUV Avantis U.S. Small Cap Value ETF | 3,929 | $382,606.69 | $471,558.58 | - | $88,951.89 | 23.25% | +0.696% |
BLND Blend Labs Inc. | 10,932 | $46,023.74 | $10,592.01 | - | -$35,431.73 | -76.99% | +5.798% |
BND Vanguard Total Bond Market Index Fund | 202,849 | $14.86M | $14.36M | - | -$500,558.65 | -3.37% | +0.554% |
BNDX Vanguard Total International Bond ETF | 25,882 | $1.3M | $1.22M | - | -$79,976.9 | -6.15% | +0.287% |
BRK-B Berkshire Hathaway Inc. | 1,115 | $510,477.84 | $589,177.05 | - | $78,699.21 | 15.42% | +0.391% |
BSV Vanguard Short-Term Bond ETF | 287,328 | $22.2M | $21.99M | - | -$204,378.88 | -0.92% | +0.177% |
DFAC Dimensional U.S. Core Equity 2 ETF | 973,802 | $25.95M | $43.84M | - | $17.88M | 68.9% | +0.29% |
DFAX Dimensional World ex U.S. Core Equity 2 ETF | 1.6M | $36.72M | $58.17M | - | $21.45M | 58.43% | -0.383% |
DFSE Dimensional Emerging Markets Sustainability Core 1 ETF | 12,889 | $398,864.23 | $598,822.94 | - | $199,958.71 | 50.13% | -0.989% |
DFSI Dimensional International Sustainability Core 1 ETF | 39,093 | $1.19M | $1.76M | - | $567,678.7 | 47.65% | +0.66% |
DFSU Dimensional US Sustainability Core 1 ETF | 38,980 | $1.11M | $1.87M | - | $753,417.05 | 67.66% | +0.472% |